Results 221 to 230 of about 81,804 (294)

An Aptamer‐Based EXACT Anticoagulant as a Sustainable, Animal‐Free Alternative to Unfractionated Heparin

open access: yesAdvanced Science, EarlyView.
By simply conjugating thrombin's active‐site inhibitor, dabigatran, with an exosite inhibitor, aptamer HD1, the resulting EXosite‐ACTive site (EXACT) inhibitors show two orders of magnitude higher potency and selectivity via synergistic binding, while maintaining the aptamer's antidote‐reversible trait, yielding a potential substitute for the animal ...
Haixiang Yu   +11 more
wiley   +1 more source

Integrin‐Piezo1 Axis Drives ECM Remodeling and Invasion of 3D Breast Epithelium

open access: yesAdvanced Science, EarlyView.
Mechanical stiffening of the extracellular matrix around mature mammary acini induces sequential remodeling phases. An early response disrupts the basement membrane and promotes fibronectin secretion, followed by delayed invasion with matrix reorganization and proliferation.
Kabilan Sakthivel   +8 more
wiley   +1 more source

Ventral tegmental area dopamine projections to the hippocampus trigger long-term potentiation and contextual learning. [PDF]

open access: yesNat Commun
Sayegh FJP   +7 more
europepmc   +1 more source

A Floating‐Gate Photoelectric Synaptic Transistor Utilizing BP/POx/WSe2 Heterostructure for Neuromorphic Visual Processing

open access: yesAdvanced Science, EarlyView.
In this paper, a novel floating gate transistor (BP/POx/WSe2) is developed, which enables rich synaptic functionality under optoelectronic conditions and can mimic human visual memory. By introducing a two‐path convolutional neural network that synergistically fuses optical and electronic inputs, it can achieve efficient feature extraction and weight ...
Yuxuan Zeng   +13 more
wiley   +1 more source

Targeted Enrichment of Engineered Bacteria on Triple‐Negative Breast Cancer Turns Immunologically Cold Tumors Hot

open access: yesAdvanced Science, EarlyView.
In this study, an “all‐in‐one” engineered anaerobic bacterial system (PDAEcN/COS) is developed for the treatment of immunologically “cold” TNBC. This nanoplatform is capable of colonizing tumor cell surfaces and implementing “self‐blocking” of immune checkpoints, while simultaneously suppressing tumor cells' “don't eat me” signals and delivering “eat ...
Xuanxiang Zhai   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy